Basic mechanisms of hemostasis.

The marked, prolonged, more generalized vasoconstriction Profilbrinolysim (plasminogen, tryptogen, prolysin, lytic factor, etc.) found in plasma and serum is activated to fibrinolysin (plasmin, tryptase, tissue lysin, etc.) by a flbrino-lysokhiase (found in tissues, especially lung and uterus). The action of the kinase is probably inhibited or antagonized by inhibitors present in plasma and serum (anti-flbrinolysokintases). The active fibrinolysin is antagonized and inhibited by antiflbrinoly- sin (antiplasmin), also found in plasma and serum. Alternatively, a proteolytic enzyme (similar to, but not identical with fibrinolysin) of prostatic origin may also lyse fibrin clots (disseminated prostatic carcinoma). Moreover, other proteolytic enzymes may also be present in human I)lasIlI as inert precursors and be occasionally activated by similar mechanisms.

[1]  J. Lewis,et al.  Partial purification of human prothrombin and proconvertin: their characteristics and interaction. , 1953, The Journal of clinical investigation.

[2]  M. Stefanini,et al.  Idiopathic thrombocytopenic purpura; a challenge. , 1953, Lancet.

[3]  M. Reissig,et al.  Electron microscopic studies of the action of thrombin on blood platelets. , 1953, Blood.

[4]  M. Stefanini,et al.  Collection, preservation and transfusion of platelets; with special reference to the factors affecting the survival rate and the clinical effectiveness of transfused platelets. , 1953, The New England journal of medicine.

[5]  F. Duckert,et al.  Purification and Physiological Properties of Factor VII from Plasma and Serum. Separation from Prothrombin , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  P. M. Aggeler,et al.  Plasma thromboplastin component (PTC), a hitherto unrecognized blood coagulation factor; case report of PTC deficiency. , 1953, Blood.

[7]  R. Rosenthal,et al.  New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  L. Lorand,et al.  The action of thrombin on fibrinogen. , 1952, The Biochemical journal.

[9]  C. Smith,et al.  Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. , 1952, Blood.

[10]  C. Scudder,et al.  Fibrin clot structure during clotting as observed in unsupported films under electron microscope. , 1952, The American journal of physiology.

[11]  A. H. Minor,et al.  A method for separating and concentrating platelets from normal human blood. , 1952, Blood.

[12]  O. Ratnoff Studies on a proteolytic enzyme in human plasma. VII. A fatal hemorrhagic state associated with excessive plasma proteolytic activity in a patient undergoing surgery for carcinoma of the head of the pancreas. , 1952, The Journal of clinical investigation.

[13]  M. Stefanini,et al.  Studies on Platelets. IV. A Thrombocytopenic Factor in Normal Human Blood, Plasma, or Serum.† , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  J. Bloom Enzyme studies on human blood. XI. The isolation and characterization of thromboplastic cell and plasma components , 1952 .

[15]  W. Whitmore,et al.  Fibrinolysis in metastatic cancer of the prostate , 1952, Cancer.

[16]  M. Paulssen,et al.  Significance of clotting factors in blood-platelets, in normal and pathological conditions. , 1951, Lancet.

[17]  B. Alexander,et al.  The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation. , 1951, The Journal of clinical investigation.

[18]  G. Ungar,et al.  STUDIES ON THE FIBRINOLYSIN-ANTIFIBRINOLYSIN SYSTEM IN SERUM , 1950, The Journal of experimental medicine.

[19]  J. Duthie,et al.  Capillary Resistance and Adrenocortical Activity , 1950, British medical journal.

[20]  M. Stefanini,et al.  Utilization of the Labile Factor During Normal and Abnormal Coagulation of Blood.∗ , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  J. Fahey,et al.  Some properties of purified prothrombin and its activation with sodium citrate. , 1950, Blood.

[22]  M. Stefanini,et al.  The state of component A (prothrombin) in human blood; evidence that it is partly free and partly in an inactive or precursor form. , 1949, The Journal of laboratory and clinical medicine.

[23]  H. D. Zucker Platelet thrombosis in human hemostasis; a histologic study of skin wounds in normal and purpuric individuals. , 1949, Blood.

[24]  M. Stefanini,et al.  THE CHEMICAL STATE OF THE CALCIUM REACTING IN THE COAGULATION OF BLOOD , 1948, The Journal of general physiology.

[25]  J. Lewis,et al.  THROMBIN FORMATION. I. THE ROLE OF CALCIUM, SERUM AC-GLOBULIN AND TISSUE THROMBOPLASTIN. , 1948, The Journal of clinical investigation.

[26]  J. Fahey,et al.  Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. , 1948, The American journal of physiology.

[27]  B. Zweifach,et al.  REACTIONS OF PERIPHERAL BLOOD VESSELS IN EXPERIMENTAL HEMORRHAGE , 1948, Annals of the New York Academy of Sciences.

[28]  W. Seegers,et al.  SERUM AC-GLOBULIN: FORMATION FROM PLASMA AC-GLOBULIN; ROLE IN BLOOD COAGULATION; PARTIAL PURIFICATION; PROPERTIES; AND QUANTITATIVE DETERMINATION , 1948 .

[29]  M. Stefanini,et al.  Activation of Plasma Thromboplastinogen and Evidence of an Inhibitor.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  A. Quick STUDIES ON THE ENIGMA OF THE HEMOSTATIC DYSFUNCTION OF HEMOPHILIA , 1947, The American journal of the medical sciences.

[31]  M. B. Zucker,et al.  Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypoprothrombinemic rats. , 1947, The American journal of physiology.

[32]  G. Ungar Endocrine function of the spleen and its participation in the pituitary-adrenal response to stress. , 1945, Endocrinology.

[33]  R. Lyons Thiol – Vitamin K Mechanism in the Clotting of Fibrinogen , 1945, Nature.

[34]  S. J. Wilson QUANTITATIVE STUDIES ON ANTITHROMBIN , 1942 .

[35]  E. Starling,et al.  The Anatomy and Physiology of Capillaries , 1923, Nature.

[36]  M. Stefanini Mechanism of blood coagulation in normal and pathologic conditions , 1953 .

[37]  J. Dacie,et al.  Christmas disease: a condition previously mistaken for haemophilia. , 1952, British medical journal.

[38]  C. Conley A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus , 1952 .

[39]  J. B. Chatterjea,et al.  Studies on platelets. II. The effect of transfusion of platelet-rich polycythemic blood on the platelets and hemostatic function in "idiopathic" and "secondary" thrombocytopenic purpura. , 1952, Blood.

[40]  J. Waldenstrom Three new cases of purpura hyperglobulinemica. A study in long-lasting benign increase in serum globulin. , 1952, Acta medica Scandinavica. Supplementum.

[41]  J. Orbison Morphology of thrombotic thrombocytopenic purpura with demonstration of aneurysms. , 1952, The American journal of pathology.

[42]  M. Stefanini Autocatalytic formation of thrombin in blood coagulation. , 1951, Acta medica Scandinavica.

[43]  J. G. Humble The mechanism of petechial hemorrhage formation. , 1949, Blood.

[44]  R. Macfarlane CRITICAL REVIEW: THE MECHANISM OF HAEMOSTASIS , 1941 .

[45]  E. Landis,et al.  Micro-injection studies of capillary blood pressure in human skin , 1930 .